Table 2 Characteristics of all patients with and without BSI
Variable | BSI N = 17 | Non BSI N = 85 | p value |
|---|---|---|---|
Gender | |||
   Male | 3 (17.6%) | 50 (57.7%) | 0.004 |
   Female | 14 (82.3%) | 35 (41.2%) |  |
Age | 49.50 ± 14.62 | 54.01 ± 1.22 | 0.293 |
Length of stay | 41.56 ± 20.05 | 17.81 ± 13.27 | < 0.001 |
Duration of neutropenia | 21.06 ± 8.33 | 5,07 ± 8,32 | < 0.001 |
Karnofsky score | 77.50 ± 16.93 | 81.40 ± 11.99 | 0.390 |
IPS score | 11.06 ± 5.10 | 6.59 ± 6.41 | 0.010 |
Apache score | 12.19 ± 4.60 | 12.38 ± 4.38 | 0.876 |
Neutropenia | 16 (94.1%) | 31 (36.5%) | < 0.001 |
Underlying disease | |||
   Infection at admission | 2 (11.7%) | 23 (27.1%) | 0.187 |
   Diabetes | 1 (5.9%) | 6 (7.1%) | 0.698 |
Underling malignancy | |||
   Acute myeloid leukemia | 13 (76.5%) | 22 (25.9%) | < 0.001 |
   Acute lymphocytic leukemia | 4 (23.5%) | 12 (14.1%) | 0.221 |
Exposure to antibiotics | 15 (88.2%) | 61 (77.7%) | 0.045 |
Exposure to chemotherapy | 13 (76.5%) | 44 (51.7%) | 0.023 |
Corticosteroid therapy | 3 (17.6%) | 37 (43.5%) | 0.057 |
Surgery procedure | 3 (17.6%) | 3 (3.5%) | 0.048 |
Bronchoscopy | 1 (5.9%) | 3 (3.5%) | 0.500 |
Gastroscopy | 1 (5.9%) | 6 (7.1%) | 0.698 |
Parenteral nutrition | 1 (5.9%) | 1 (1.2%) | 0.290 |
Bladder catheter | 2 (11.7%) | 7 (8.2%) | 0.429 |
CVC | 2 (11.7%) | 2 (2.3%) | 0.115 |
Hickman catheter | 6 (35.3%) | 11 (12.9%) | 0.025 |
Peripheral venous catheter | 12 (70.60%) | 77 (90.6%) | 0.119 |
Death | 1 (5.9%) | 7 (8.2%) | 0.634 |